Josep Domingo-Domenech Department of Pathology Icahn School of Medicine at Mount Sinai Biography Publications Institution JoVE Articles Josep Domingo-Domenech has not added a biography. If you are Josep Domingo-Domenech and would like to personalize this page please email our Author Liaison for assistance. Publications Targeting Sarcoma Tumor-initiating Cells Through Differentiation Therapy Stem Cell Research. May, 2017 | Pubmed ID: 28433655 The Role of GATA2 in Lethal Prostate Cancer Aggressiveness Nature Reviews. Urology. Jan, 2017 | Pubmed ID: 27872477 Tumour Initiating Cells and IGF/FGF Signalling Contribute to Sorafenib Resistance in Hepatocellular Carcinoma Gut. Mar, 2017 | Pubmed ID: 26658144 Definitive Management of Primary Bladder Tumors in the Context of Metastatic Disease: Who, How, When, and Why? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Oct, 2016 | Pubmed ID: 27551117 Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Oncology. 2016 | Pubmed ID: 27077749 A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer Cancer Cell. Feb, 2015 | Pubmed ID: 25670080 Advances in the Management of Muscle-invasive Bladder Cancer Through Risk Prediction, Risk Communication, and Novel Treatment Approaches Clinical Advances in Hematology & Oncology : H&O. Feb, 2013 | Pubmed ID: 23598909 A Common MicroRNA Signature Consisting of MiR-133a, MiR-139-3p, and MiR-142-3p Clusters Bladder Carcinoma in Situ with Normal Umbrella Cells The American Journal of Pathology. Apr, 2013 | Pubmed ID: 23410519 Suppression of Acquired Docetaxel Resistance in Prostate Cancer Through Depletion of Notch- and Hedgehog-dependent Tumor-initiating Cells Cancer Cell. Sep, 2012 | Pubmed ID: 22975379 A BAC-based Transgenic Mouse Specifically Expresses an Inducible Cre in the Urothelium PloS One. 2012 | Pubmed ID: 22496911 PAX7-FKHR Fusion Gene Inhibits Myogenic Differentiation Via NF-kappaB Upregulation Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Mar, 2012 | Pubmed ID: 22374423 Anatomical Features of the Urethra and Urinary Bladder Catheterization in Female Mice and Rats. An Essential Translational Tool Acta Cirúrgica Brasileira / Sociedade Brasileira Para Desenvolvimento Pesquisa Em Cirurgia. 2011 | Pubmed ID: 22030824 Predictive Value of Microtubule Associated Proteins Tau and Stathmin in Patients with Nonmuscle Invasive Bladder Cancer Receiving Adjuvant Intravesical Taxane Therapy The Journal of Urology. Nov, 2011 | Pubmed ID: 21944130 Distinct Expression Profiles of P63 Variants During Urothelial Development and Bladder Cancer Progression The American Journal of Pathology. Mar, 2011 | Pubmed ID: 21356385 Molecular Pathways of Urothelial Development and Bladder Tumorigenesis Urologic Oncology. Jul-Aug, 2010 | Pubmed ID: 20610278 Loco-regional Control After Postoperative Radiotherapy for Patients with Regional Nodal Metastases from Melanoma Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Oct, 2009 | Pubmed ID: 19828412 Inactivation of NF-kappaB by Proteasome Inhibition Contributes to Increased Apoptosis Induced by Histone Deacetylase Inhibitors in Human Breast Cancer Cells Breast Cancer Research and Treatment. Nov, 2008 | Pubmed ID: 18064564 Prognostic Implications of Protein S-100beta Serum Levels in the Clinical Outcome of High-risk Melanoma Patients Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine. 2007 | Pubmed ID: 17962723 Toxicity of Combined Treatment of Adjuvant Irradiation and Interferon Alpha2b in High-risk Melanoma Patients Melanoma Research. Oct, 2007 | Pubmed ID: 17885585 Clinical Outcome After Surgical Resection of Lung Metastases from Melanoma Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Jan, 2007 | Pubmed ID: 17272230 Interleukin 6, a Nuclear Factor-kappaB Target, Predicts Resistance to Docetaxel in Hormone-independent Prostate Cancer and Nuclear Factor-kappaB Inhibition by PS-1145 Enhances Docetaxel Antitumor Activity Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2006 | Pubmed ID: 17000695 Whole Brain Irradiation and Temozolomide Based Chemotherapy in Melanoma Brain Metastases Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Apr, 2006 | Pubmed ID: 16648102 Differential Cellular and Molecular Effects of Bortezomib, a Proteasome Inhibitor, in Human Breast Cancer Cells Molecular Cancer Therapeutics. Mar, 2006 | Pubmed ID: 16546981 Low Thymidylate Synthase Expression in the Primary Tumor Predicts Favorable Clinical Outcome in Resected Gastric Cancer Patients Treated with Adjuvant Tegafur Oncology. 2004 | Pubmed ID: 15218314 [Fulminant Hepatic Failure As Form of Presentation of a Peripheral T Cell Lymphoma] Medicina Clínica. Nov, 2002 | Pubmed ID: 12459111 Изоляция и характеристика опухолевых клеток от саркомы пациента полученных Xenografts Dan Han1, Veronica Rodriguez-Bravo1, Sudeh Izadmehr1, Josep Domingo-Domenech1, Carlos Cordon-Cardo1 1Department of Pathology, Icahn School of Medicine at Mount Sinai JoVE 57011 암 연구학 Поколение моделей клеток рака простаты сопротивления против митотическая агент доцетаксел Lisa Mohr1, Marc Carceles-Cordon1, Jungreem Woo1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1, Veronica Rodriguez-Bravo1,2 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai JoVE 56327 암 연구학 Генерация пациента рака простаты Производные ксенотрансплантат модели от циркулирующих опухолевых клеток Estrelania S. Williams1, Veronica Rodriguez-Bravo3, Uma Chippada-Venkata2, Janis De Ia Iglesia-Vicente1, Yixuan Gong2, Matthew Galsky2, William Oh2, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 3Molecular Biology Program, Memorial Sloan-Kettering Cancer Center 의학 Выделение стволовых клеток рака из образцов предстательной железы человека Samuel J. Vidal1, S. Aidan Quinn1, Janis de la Iglesia-Vicente1, Dennis M. Bonal1, Veronica Rodriguez-Bravo2, Adolfo Firpo-Betancourt1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Icahn School of Medicine at Mount Sinai, 2Molecular Biology Program, Memorial Sloan-Kettering Cancer Center JoVE 51332 의학
Изоляция и характеристика опухолевых клеток от саркомы пациента полученных Xenografts Dan Han1, Veronica Rodriguez-Bravo1, Sudeh Izadmehr1, Josep Domingo-Domenech1, Carlos Cordon-Cardo1 1Department of Pathology, Icahn School of Medicine at Mount Sinai JoVE 57011 암 연구학
Поколение моделей клеток рака простаты сопротивления против митотическая агент доцетаксел Lisa Mohr1, Marc Carceles-Cordon1, Jungreem Woo1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1, Veronica Rodriguez-Bravo1,2 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai JoVE 56327 암 연구학
Генерация пациента рака простаты Производные ксенотрансплантат модели от циркулирующих опухолевых клеток Estrelania S. Williams1, Veronica Rodriguez-Bravo3, Uma Chippada-Venkata2, Janis De Ia Iglesia-Vicente1, Yixuan Gong2, Matthew Galsky2, William Oh2, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 3Molecular Biology Program, Memorial Sloan-Kettering Cancer Center 의학
Выделение стволовых клеток рака из образцов предстательной железы человека Samuel J. Vidal1, S. Aidan Quinn1, Janis de la Iglesia-Vicente1, Dennis M. Bonal1, Veronica Rodriguez-Bravo2, Adolfo Firpo-Betancourt1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Icahn School of Medicine at Mount Sinai, 2Molecular Biology Program, Memorial Sloan-Kettering Cancer Center JoVE 51332 의학
